In a landmark move, the Supreme Court of India refused to block Natco Pharma from producing a low-cost version of Roche’s SMA drug, Evrysdi, marking a powerful stand for affordable healthcare. The Roche-Natco SMA drug patent dispute underscores India’s constitutional commitment to prioritize life over profit, reaffirming its legacy as the world’s pharmacy.

Supreme Court acquits two accused in Saheb v. State of Maharashtra, stressing proof beyond reasonable doubt for convictions.